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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 47, Revision 1 
(FGE.47Rev1): 
Bi- and tricyclic secondary alcohols, ketones and related esters from 
chemical group 81 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to evaluate six flavouring substances in the Flavouring Group 
Evaluation 47, including an additional two substances in this Revision 1, using the Procedure in 
Commission Regulation (EC) No 1565/2000. None of the substances were considered to have 
genotoxic potential. The substances were evaluated through a stepwise approach (the Procedure) that 
integrates information on structure-activity relationships, intake from current uses, toxicological 
threshold of concern, and available data on metabolism and toxicity. The Panel concluded that the six 
substances [FL-no: 02.119, 07.171, 07.196, 09.584, 09.848 and 09.888] do not give rise to safety 
concern at their levels of dietary intake, estimated on the basis of the MSDI approach. Besides the 
safety assessment of these flavouring substances, the specifications for the materials of commerce 
have also been considered. Adequate specifications including complete purity criteria and identity for 
the materials of commerce have been provided for all six candidate substances. 
 
© European Food Safety Authority, 2012 
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SUMMARY  
The European Food Safety Authority (EFSA) asked the Scientific Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (the Panel) to advise the Commission on the implications 
for human health of chemically defined flavouring substances used in or on foodstuffs in the Member 
States. In particular, the Panel is asked to evaluate six flavouring substances in the Flavouring Group 
Evaluation 47, Revision 1 (FGE.47Rev1), using the Procedure as referred to in the Commission 
Regulation EC No 1565/2000. These six flavouring substances belong to chemical group 7 and 8, 
Annex I of the Commission Regulation EC No 1565/2000. 
The present revision of FGE.47, FGE.47Rev1, comprises the evaluation of six candidate flavouring 
substances. Four of these have been evaluated in the previous version (FGE.47). Two additional 
candidate substances, cedrenol [FL-no: 02.119] and pin-2-en-4-one [FL-no: 07.196], have now been 
included, following their separate evaluation for genotoxic potential in FGE.211 and FGE.212Rev1, 
because of the presence of structural alerts for genotoxicity. 
The six candidate substances are one tricyclic alcohol [FL-no: 02.119], two bicyclic ketones [FL-no: 
07.171 and 07.196] and three esters of bicyclic secondary alcohols [FL-no: 09.584, 09.848 and 
09.888]. 
All six candidate substances possess one or more chiral centres. The stereoisomeric composition has 
been specified for all six substances.  
Four candidate substances belong to structural class I and two candidate substances belong to 
structural class II according to the decision tree approach as presented by Cramer et al., 1978. 
Three candidate substances [FL-no: 02.119, 07.171 and 07.196] in the present group have been 
reported to occur naturally. 
In its evaluation, the Panel as a default used the Maximised Survey-derived Daily Intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
According to the default MSDI approach, the candidate substances in this group have intakes in 
Europe from 0.011 to 34 microgram/capita/day, which are below the thresholds of concern values for 
structural class I (1800 microgram/person/day) and structural class II (540 microgram/person/day) 
substances. 
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the four candidate substances belonging to structural class I would result in a combined 
intake of approximately 35 microgram/capita/day and for the two substances assigned to structural 
class II to 15 microgram/day. These values are lower than the thresholds of concern for structural class 
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I or class II substances (1800 or 540 microgram/person/day, respectively). The total combined intakes 
of candidate and supporting substances in Europe are approximately 1200 and 70 
microgram/capita/day, for structural class I substances and for structural class II substances, 
respectively, which do not exceed the thresholds of concern for structural class I and II. 
For two of the candidate substances [FL-no: 02.119 and 07.196] it has been concluded in FGE.211 and 
FGE.212Rev1, respectively, that a concern for genotoxicity, indicated by the presence of a structural 
alert, could be ruled out based on experimental data for structurally related substances. Thus, these two 
substances can be evaluated through the Procedure. For the remaining four substances, genotoxicity 
data are available only for a limited number of supporting substances, and the genotoxicity could not 
be assessed adequately. However, the data available do not preclude the evaluation of these four 
candidate substances using the Procedure. 
The six candidate substances are expected to be metabolised to innocuous products. 
It was noted that where toxicity data were available they were consistent with the conclusions in the 
present flavouring group evaluation using the Procedure. 
It is considered that on the basis of the default MSDI approach the six candidate substances would not 
give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI approach, they ranged for the four candidate 
substances in structural class I from 1900 to 3900 microgram/person/day. These intakes are above the 
threshold of concern for structural class I of 1800 microgram/person/day. The estimated intake of the 
two candidate substances [FL-no: 07.171 and 07.196] assigned to structural class II, based on the 
mTAMDI approach, is 1000 microgram/person/day each, which is above the threshold of concern for 
structural class II of 540 microgram/person/day.  
Thus, for the four candidate substances from structural class I and for the two candidate substances 
allocated to structural class II, the intakes, estimated on the basis of the mTAMDI approach, exceed 
the relevant threshold for the structural class. Therefore, for all six substances more reliable exposure 
data are required. On the basis of such additional data, these flavouring substances should be 
reconsidered using the Procedure. Subsequently, additional toxicity data might become necessary. 
In order to determine whether the conclusion for the candidate substances can be applied to the 
materials of commerce, it is necessary to consider the available specifications. Specifications including 
complete purity criteria for the materials of commerce have been provided for all six candidate 
substances.  
Thus, for all six candidate substances [FL-no: 02.119, 07.171, 07.196, 09.584, 09.848 and 09.888], the 
Panel concluded that they would present no safety concern at the level of intake estimated on the basis 
of the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
HISTORY OF THE EVALUATION  
The Flavouring Group Evaluation 47, FGE.47 dealt with one bicyclic ketone and three esters of 
bicyclic secondary alcohols. The original submissions from Industry (EFFA, 2005f; EFFA, 2006ac) 
included two candidate substances [FL-no: 02.119 and 07.196], which are alpha, beta-unsaturated 
ketones, for which further evaluation of genotoxic potential was required before they could be 
evaluated using the Procedure. The two substances were evaluated with respect to genotoxicity in 
FGE.211 and FGE.212.  
FGE Opinion 
adopted by 
EFSA 
Link No. of 
candidate 
substances 
FGE.47 22 May 2008 http://www.efsa.europa.eu/en/efsajournal/pub/743.htm 4 
FGE.47Rev1 22 March 
2012 
 6 
 
The present revision of FGE.47, FGE.47Rev1, includes the assessment of the two additional candidate 
substances [FL-no: 02.119 and 07.196] considered with respect to genotoxicity in FGE.211 and 
FGE.212Rev1 (EFSA, 2011e; EFSA, 2011f). In these FGEs the Panel concluded that the data 
available ruled out the concern for genotoxicity and thus concluded that these two substances can be 
evaluated through the Procedure. 
No further toxicity and/or metabolism data were provided by Industry for these two substances. A 
search in open literature provided additional information on the acute toxicity of cedrenol [FL-no: 
02.119]. This information has also been included in this revision. 
FGE.47Rev1 also includes additional information submitted by the Industry (EFFA, 2010a) on 
specifications for [FL-no: 07.171, 09.584, 09.848 and 09.888], which had been requested in FGE.47. 
During the revision process the Panel recognised that although d-camphor [FL-no: 07.215] could not 
be used as a supporting substance for acute toxicity of the candidate substances in this FGE, it is 
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sufficiently structurally related to support the evaluation of the candidate substances in this FGE with 
respect to chronic toxicity, reproductive toxicity and genotoxicity. Therefore, data on d-camphor have 
been introduced in this revision of FGE.47. 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register (Commission decision 1999/217/EC), according to Commission Regulation 
(EC) No 1565/2000 (EC, 2000a), prior to their authorisation and inclusion in the Union list 
(Regulation (EC) No 1334/2008). The evaluation programme was finalised at the end of 2009. 
After the finalisation of the evaluation programme, in their letters of the 7th May 2010 and 3rd June, the 
Commission requested EFSA, based on additional submitted data on genotoxicity, to carry out re-
evaluation of the flavouring substances pin-2-en-4-one [FL-no: 07.196] and cedrenol [FL-no: 02.119], 
and depending on the outcome, to proceed to the evaluation of these flavouring substances through the 
Procedure, also according to Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 47, Revision1 
1.1. Description 
The present Flavouring Group Evaluation 47, Revision 1 (FGE.47Rev1), using the Procedure as 
referred to in the Commission Regulation EC No 1565/2000 (EC, 2000a) (The Procedure – shown in 
schematic form in Annex I of this FGE), deals with one tricyclic secondary alcohol [FL-no: 02.119], 
two bicyclic ketone [FL-no: 07.171 and 07.196] and three esters of bicyclic secondary alcohols [FL-
no: 09.584, 09.848 and 09.888]. All six flavouring substances (candidate substances) belong to 
chemical group 8, according to Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
The six flavouring substances under consideration, as well as their chemical Register names, FLAVIS- 
(FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor and Extract 
Manufactures Association- (FEMA-) numbers, structure and specifications, are listed in Table 1.  
The hydrolysis products of candidate substances are listed in Table 2b. 
The six candidate substances are structurally related to 16 flavouring substances (supporting 
substances) evaluated at the 63rd meeting of the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) in the group “Monocyclic and Bicyclic Secondary Alcohols, Ketones and 
Related Esters” (JECFA, 2006a).  
The names and structures of the 16 supporting substances are listed in Table 3, together with their 
evaluation status (CoE, 1992; SCF, 1995; JECFA, 2006a). 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
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substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number, etc.). 
The six candidate substances, cedrenol [FL-no: 02.119], isopinocamphone [FL-no: 07.171], pin-2-en-
4-one [FL-no: 07.196], isobornyl isobutyrate [FL-no: 09.584], (1S-endo)-1,7,7-
trimethylbicyclo[2.2.1]heptan-2-ol acetate [FL-no: 09.848] and isobornyl 2-methylbutyrate [FL-no: 
09.888], possess one or more chiral centres. For all six substances the stereoisomeric composition has 
been specified (See Table 1). 
1.3. Natural Occurrence in Food 
Three candidate substances have been reported to occur in apricot, citrus fruits, mango, cloudberry and 
essential oils (TNO, 2000; TNO, 2011). Quantitative data on the natural occurrence have been 
reported for these substances:  
• Cedrenol [FL-no: 02.119]: up to 500 mg/kg in citrus fruits 
• Isopinocamphone [FL-no: 07.171]: up to 2.2 mg/kg in apricot 
• Pin-2-en-4-one [FL-no: 07.196]: up to 500 mg/kg in citrus fruits, 3.5 mg/kg in apricot, 2.7 
mg/kg in mango. 
 
The remaining three substances (isobornyl isobutyrate [FL-no: 09.584], (1S-endo)-1,7,7-
trimethylbicyclo[2.2.1]heptan-2-ol acetate [FL-no: 09.848] and isobornyl 2-methylbutyrate [FL-no: 
09.888]) have not been reported to occur naturally in any food items according to TNO (TNO, 2000). 
2. Specifications 
Purity criteria for the six substances have been provided by the Flavour Industry (EFFA, 2005f; 
EFFA, 2006ac). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), this information is adequate for all six candidate substances (see Section 1.2 and Table 1). 
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI-approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
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One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (i.e., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995a). The intake approach does not consider the possible natural 
occurrence in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present FGE.47Rev1, the total annual production volume of the candidate substances for use as 
flavouring substances in Europe has been reported to be approximately 400 kg (EFFA, 2005f; EFFA, 
2006ac). For the supporting substances, the total annual volume of production has been reported by 
the JECFA to be approximately 9700 kg (isobornyl acetate [FL-no: 09.218] accounts for 7300 kg, 
(1R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one [FL-no: 07.215] for 410 kg, borneol [FL-no: 02.016] 
for 1100 kg and fenchyl alcohol [FL-no: 02.038] for 450 kg) (JECFA, 2005c; JECFA, 2009c).  
On the basis of the annual volume of production reported for the candidate substances, the daily per 
capita intakes for each of these flavourings have been estimated. The estimated MSDI of cedrenol 
[FL-no: 02.119] from use as a flavouring substance is 34 microgram and that of pin-2-en-4-one [FL-
no: 07.196] is 15 microgram. For each of the remaining substances the estimated daily per capita 
intake is equal to or less than 0.085 microgram for each (Table 2a). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are available, and is 
consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No production data are available for 
the enlarged EU. 
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For all six candidate substances information on food categories and normal and maximum use 
levels5,6,7 were submitted by the Flavour Industry (EFFA, 2005f; EFFA, 2006ac; EFFA, 2007a). The 
candidate substances are used in flavoured food products divided into the food categories, outlined in 
Annex III of the Commission Regulation (EC) No 1565/2000 (EC, 2000a), as shown in Table 3.1. For 
the present calculation of mTAMDI, the reported normal use levels were used. In the case where 
different use levels were reported for different food categories the highest reported normal use level 
was used. 
 
Table 3.1 Use of Candidate Substances  
Food 
category 
Description Flavourings used 
01.0 Dairy products, excluding products of category 2 All 
02.0 Fats and oils, and fat emulsions (type water-in-oil) All 
03.0 Edible ices, including sherbet and sorbet All 
04.1 Processed fruits All 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
None 
05.0 Confectionery All 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
All 
07.0 Bakery wares All 
08.0 Meat and meat products, including poultry and game All 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  All 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey None 
12.0 Salts, spices, soups, sauces, salads, protein products etc. All 
13.0 Foodstuffs intended for particular nutritional uses All 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products Only [FL-no: 02.119] 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts All 
15.0 Ready-to-eat savouries All except [FL-no: 
09.888] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
All 
 
According to the Flavour Industry the normal use levels for the six candidate substances are in the 
range of 1 - 20 mg/kg food, and the maximum use levels are in the range of 5 - 100 mg/kg (EFFA, 
2002i; EFFA, 2005f; EFFA, 2006ac; EFFA, 2007a) (see Table II.1.2, Annex II). 
The mTAMDI values for the four candidate substances from structural class I range from 1900 to 
3900 microgram/person/day. For both candidate substances from structural class II the mTAMDI is 
1000 microgram/person/day. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
                                                     
 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile of reported 
usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived 
from 12 model flavouring substances (EFFA, 2004e). 
7 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 14.2 
“Alcoholic beverages” for substances for which no data have been given for food category 14.2 (EFFA, 2007a). 
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4. Absorption, Distribution, Metabolism and Elimination 
The available data indicate that the three esters in this group [FL-no: 09.584, 09.848 and 09.888] are 
readily hydrolysed to the corresponding bicyclic secondary alcohols which are subsequently 
conjugated with glucuronic acid and excreted in the urine. Similarly conjugation with glucuronide will 
also occur with the free tri-cyclic alcohol cedrenol [FL-no: 02.119]. The major metabolic pathway of 
the two bicyclic ketones [FL-no: 07.171 and 07.196], involves reduction to the corresponding 
secondary alcohols, which will be excreted primarily as the glucuronic acid conjugate. In addition to 
reductive pathways, alicyclic ketones and, to a lesser extent, secondary alcohols containing an alkyl 
side-chain undergo oxidation of the side-chain to form polar oxygenated metabolites that are excreted 
mainly in the urine, either unchanged or as glucuronide or sulphate conjugates. It is therefore 
concluded that the candidate substances can be anticipated to be metabolised to innocuous products. 
For more detailed information, see Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the six candidate substances from chemical group 7 and 8 the Procedure as 
outlined in Annex I was applied, based on the MSDI approach. The stepwise evaluations of the 
substances are summarised in Table 2a. 
Step 1 
Four candidate substances are classified into structural class I [FL-no: 02.119, 09.584, 09.848 and 
09.888] and two [FL-no: 07.171 and 07.196] into structural class II according to the decision tree 
approach presented by Cramer et al. (Cramer et al., 1978). 
Step 2 
All six candidate substances in this group are expected to be metabolised to innocuous products. The 
evaluation of these substances therefore proceeded via the A-side of the Procedure scheme. 
Step A3 
The candidate substances [FL-no: 02.119, 07.171, 07.196, 09.584, 09.848 and 09.888] have estimated 
European daily per capita intakes ranging from 0.011 to 34 microgram (Table 2a). These intakes are 
below the threshold of concern of 1800 microgram/person/day for structural class I and 540 
microgram/person/day for structural class II substances.  
Based on results of the safety evaluation sequence of the Procedure, these six candidate substances, 
proceeding via the A-side of the Procedure scheme, do not pose a safety concern when used as 
flavouring substances at the estimated levels of intake, based on the MSDI approach. 
6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intakes for the four candidate substances in structural class I based on the mTAMDI 
range from 1900 to 3900 microgram/person/day. For all these substances the mTAMDI is above the 
threshold of concern of 1800 microgram/person/day. 
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The estimated intake of the two substances assigned to structural class II, based on the mTAMDI, is 
1000 microgram/person/day each, which is above the threshold of concern for structural class II 
substances of 540 microgram/person/day. 
Thus, for all candidate substances [FL-no: 02.119, 07.171, 07.196, 09.584, 09.848 and 09.888] further 
information is required. This would include more reliable intake data and then, if necessary, additional 
toxicological data. 
For comparison of the MSDI and mTAMDI values, see Table 6.1. 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.119 Cedrenol 34 3900 Class I 1800 
09.584 Isobornyl isobutyrate 0.085 2300 Class I 1800 
09.848 (1S-endo)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-ol acetate 
0.011 2300 Class I 1800 
09.888 Isobornyl 2-methylbutyrate 0.061 1900 Class I 1800 
07.171 Isopinocamphone 0.024 1000 Class II 540 
07.196 Pin-2-en-4-one 15 1000 Class II 540 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2005f; EFFA, 2006ac) the 
combined estimated per capita intake as flavouring of the four candidate substances assigned to 
structural class I is 35 microgram/day, and of the two substances assigned to structural class II, 15 
microgram/day. These values do not exceed the thresholds of concern for substances belonging to 
structural class I and II of 1800 and 540 microgram/person/day, respectively. 
The candidate substances are structurally related to 16 flavouring substances (13 are structural class I 
substances, three are structural class II substances) evaluated by JECFA at its 63rd session (JECFA, 
2006a). The estimated total combined intake of candidate and supporting substances (in Europe) 
would be 1200 microgram/capita/day for structural class I substances, which is below the threshold of 
concern for structural class I of 1800 microgram/person/day. The estimated total combined intake of 
candidate and supporting substances (in Europe) would be 70 microgram/capita/day for structural 
class II substances, which is below the threshold of concern for structural class II of 540 
microgram/person/day. 
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8. Toxicity 
8.1. Acute Toxicity 
Data are available on the candidate substance cedrenol [FL-no: 02.119] and on nine supporting 
substances. For cedrenol an oral LD50 value of  > 5000 mg/kg bw has been reported for rats (Opdyke, 
1975b). For the supporting substances LD50
 
values ranging from 5000 mg/kg bw to more than 10000 
mg/kg body weight (bw) have been reported. The Panel noted that due to the limited reporting, the 
validities of these LD50 are difficult to assess. 
The acute toxicity data are summarised in Annex IV, Table IV.1. 
The Panel is aware that there are acute toxicity data on adults and children for one supporting 
substance, (1R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one (camphor [FL-no: 07.215]), mostly arising 
from the accidental ingestion of camphor-containing medications. The probable lethal oral bolus dose 
has been reported to be in the range of 50 to 500 mg/kg bw. No acute toxicity was reported after doses 
lower than 2 mg/kg bw and clinically insignificant signs of toxicity may be seen in sensitive 
individuals at doses of 5 mg/kg bw and higher, whereas clinically manifest toxicity in sensitive 
persons would require doses higher than 30 mg/kg bw. The Panel therefore suggested that maximum 
limits should be set to ensure that exposure to camphor does not exceed 2 mg/kg bw on a single day in 
any age group (EFSA, 2008l). 
As discussed in Annex III, camphor is rapidly metabolised to hydroxylated products which are then 
excreted. Under the anticipated conditions of dietary exposure from a food matrix, these metabolic 
pathways are the major routes for detoxification and would not be expected to be saturated. The 
reduction of camphor to borneol and isoborneol is only a minor metabolic pathway. In rat liver 
preparations, the 2-keto group of d-camphor underwent no detectable reduction; l-camphor was 
reduced to a small extent. Rabbit liver cytosol mediated a vigorous stereospecific endo-reduction of d-
camphor to borneol; a small amount (1 %) of isoborneol was also formed. After oral administration of 
camphor to rabbits a reduction to borneol was observed to some extent, whereas in dogs only 
excretion of hydroxylated camphor was reported. In humans admitted to hospital in a state of acute 
intoxication after ingestion of 6 - 10 g camphor, no reduction products but only 5- and 8-(or 9)- 
hydroxycamphor and their conjugates were detected as metabolites. Thus, the acute toxicity of 
camphor is not likely to be attributable to metabolism to borneol or isoborneol, which are hydrolysis 
products of three of the candidate substances in this FGE.  
The Panel therefore considers that the acute human toxicity findings on camphor, a substance 
structurally related to the candidate substances in this FGE, are not relevant for the safety assessment 
of the candidate flavouring substances or their hydrolysis products. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
There are no data available on the candidate substances, but there are data on four of the supporting 
substances. 
Repeated dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
There are no data available on the candidate substances, but there are data on one supporting 
substance. 
Developmental/reproductive toxicity data are summarised in Annex IV, Table IV.3. 
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8.4. Genotoxicity Studies  
There are no genotoxicity data available for the candidate substances. Therefore the genotoxic 
potential of the candidate substances in this FGE was assessed from data available for supporting 
substances. 
Due to the presence of a structural alert for genotoxicity (“alpha,beta-unsaturated carbonyl moiety”) 
for two candidate substances [FL-no: 02.119 and 07.196], these two substances had to be further 
assessed in separate FGEs: 
• In FGE.211 it was concluded for candidate substance [FL-no: 02.119] that based on new in 
vitro genotoxicity data on 1(7),8-p-menthadien-2-yl acetate [FL-no: 09.930], no genotoxic 
potential is indicated. 
 
• In FGE.212Rev1 it was concluded for candidate substance [FL-no: 07.126] that based on 
additional genotoxicity information on isophorone [FL-no: 07.126], no genotoxic potential is 
indicated. 
Therefore, these two substances [FL-no: 02.119 and 07.126] can be evaluated using the Procedure. 
In vitro  
Borneol [FL-no: 02.016] and isobornyl propionate [FL-no: 09.131] were consistently tested negative 
in the Ames assay when a variety of Salmonella typhimurium strains including TA97, TA98, TA100, 
TA1535, TA1537 and TA1538 were incubated with up to 5,000 μg/plate with or without metabolic 
activation (Azizan and Blevins, 1995; Simmon et al., 1977; Wild et al., 1983).  
Borneol showed no mutagenic activity when tested in Escherichia coli WP2 uvrA at concentrations up 
to 3,200 μg/plate (Yoo, 1986). 
In the Rec-assay, borneol was reported to induce growth inhibition in Bacillus subtilis strain M45- 
 
when tested at concentrations of up to 10 mg/disk (Yoo, 1986). This test has very limited relevance for 
the genotoxicity evaluation. 
No indication of genotoxic activity was obtained in four bacterial reverse mutation assays in 
Salmonella typhimurium and in two SCE assays in Chinese hamster ovary cells with the supporting 
substance (1R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one [FL-no: 07.215] (d-camphor). A bacterial 
reverse mutation assay with d,l-camphor was also negative. 
In vivo  
The genotoxic potential of isobornyl propionate [FL-no: 09.131] to induce somatic mutations in adult 
Drosophila melanogaster was studied in a Basc test. No increased frequency of mutation was 
observed when a 10 mM solution of isobornyl propionate was fed to the flies for 3 days (Wild et al., 
1983).  
In the micronucleus test, groups of NMRI mice administered intraperitoneal doses of 841, 1,893 or 
2,944 mg/kg bw isobornyl propionate showed no increase in micronucleated erythrocytes in bone 
marrow samples, 30 hours post administration (Wild et al., 1983).  
No indication for enhanced micronucleus formation was obtained with the supporting substance d,l-
camphor in mouse erythrocytes in peripheral blood after topical administration (NTP, 1999c).  
Conclusion on genotoxicity 
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For two candidate substances [FL-no: 02.119 and 07.196] it was concluded in FGE.211 (EFSA, 
2011e) and FGE.212Rev1 (EFSA, 2011f) that a concern for genotoxicity, indicated by the presence of 
a structural alert, could be ruled out based on experimental data for structurally related substances. For 
the remaining four substances [FL-no: 07.171, 09.584, 09.848 and 09.888], genotoxicity data are 
available only for a limited number of supporting substances, and the genotoxicity could not be 
assessed adequately. However, the data available do not preclude the evaluation of these four 
candidate substances using the Procedure. 
Genotoxicity data are summaries in Annex IV, Table IV.4 and Table IV.5. 
9. Conclusions 
The present revision of FGE.47, FGE.47Rev1, comprises the evaluation of six candidate flavouring 
substances. Four of these were evaluated in the previous version (FGE.47). Two additional candidate 
substances [FL-no: 02.119 and 07.196] were included following their separate evaluation for 
genotoxic potential in FGE.211 and FGE.212Rev1, due to the presence of structural alerts for 
genotoxicity. 
The six candidate substances are one tricyclic alcohol [FL-no: 02.119], two bicyclic ketone [FL-no: 
07.171 and 07.196] and three esters of bicyclic secondary alcohols [FL-no: 09.584, 09.848 and 
09.888]. 
All candidate substances possess one or more chiral centres. The stereoisomeric composition has been 
specified for all six substances.   
Four candidate substances belong to structural class I and two candidate substances have been 
assigned to structural class II according to the decision tree approach as presented by Cramer et al., 
1978. 
Three candidate substances [FL-no: 02.119, 07.171 and 07.196] in the present group have been 
reported to occur naturally. 
According to the default MSDI approach, the candidate substances in this group have intakes in 
Europe from 0.011 to 34 microgram/capita/day, which are below the thresholds of concern values for 
structural class I (1800 microgram/person/day) and structural class II (540 microgram/person/day) 
substances. 
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the four candidate substances belonging to structural class I would result in a combined 
intake of approximately 35 microgram/capita/day and to 15 microgram/day for the two substances 
assigned to structural class II. These values are lower than the thresholds of concern for structural class 
I or class II substances (1800 or 540 microgram/person/day, respectively). The total combined intakes 
of candidate and supporting substances in Europe are approximately 1200 and 70 
microgram/capita/day, for structural class I substances and for structural class II substances, 
respectively, which also do not exceed the thresholds of concern for structural class I and II. 
For two of the candidate substances it has been concluded in FGE.211 and FGE.212Rev1, 
respectively, that a concern for genotoxicity, indicated by the presence of a structural alert, could be 
ruled out based on experimental data for structurally related substances. Thus, these two substances 
can be evaluated through the Procedure. For the remaining four substances, genotoxicity data are 
available only for a limited number of supporting substances, and the genotoxicity could not be 
assessed adequately. However, the data available do not preclude the evaluation of these four 
candidate substances using the Procedure. 
The six candidate substances are expected to be metabolised to innocuous products. 
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It was noted that where toxicity data were available they were consistent with the conclusions in the 
present flavouring group evaluation using the Procedure. 
It is considered that on the basis of the default MSDI approach the candidate substances would not 
give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI approach, they ranged from 1900 to 3900 
microgram/person/day for the four candidate substances from structural class I. These intakes are 
above the threshold of concern for structural class I of 1800 microgram/person/day. The estimated 
intake of the two candidate substances [FL-no: 07.171 and 07.196] assigned to structural class II, 
based on the mTAMDI approach, is 1000 microgram/person/day each, which is above the threshold of 
concern for structural class II of 540 microgram/person/day.  
Thus, for the four candidate substances from structural class I and for the two candidate substances 
allocated to structural class II, the intakes, estimated on the basis of the mTAMDI approach, exceed 
the relevant threshold for the structural class. Therefore, for all six candidate substances more reliable 
exposure data are required. On the basis of such additional data, these flavouring substances should be 
reconsidered using the Procedure. Subsequently, additional toxicity data might become necessary. 
In order to determine whether the conclusion for the candidate substances can be applied to the 
materials of commerce, it is necessary to consider the available specifications. Specifications including 
complete purity criteria for the materials of commerce have been provided for all six candidate 
substances.   
Thus, for all six candidate substances [FL-no: 02.119, 07.171, 07.196, 09.584, 09.848 and 09.888], the 
Panel concluded that they would present no safety concern at the level of intake estimated on the basis 
of the MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN FGE.47REV1 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 47Rev1 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
02.119 
 
Cedrenol    
OH
 
 
10189 
28231-03-0 
Solid 
C15H24O 
220.35 
Practically insoluble 
or insoluble 
Soluble 
98 (0.27 hPa) 
128 
MS 
95 % 
n.a. 
n.a. 
 
Complex mixture of 
diastereoisomers (EFFA, 
2012g). (Stereoisomeric 
composition not specified). 
07.171 
 
Isopinocamphone    
O
 
4198 
11125 
18358-53-7 
Liquid 
C10H16O 
152.24 
Insoluble 
Freely soluble 
70 (7 hPa) 
 
MS 
95 % 
1.472-1.478 
0.963-0.969 
 
Mixture of diastereoisomers. 
Approx. 25 % of each 
(EFFA, 2012g). 
07.196 
 
Pin-2-en-4-one    
O  
4216 
11186 
80-57-9 
Liquid 
C10H14O 
150.22 
Insoluble 
Freely soluble 
90 (16 hPa) 
 
NMR MS 
95 % 
1.492-1.498 
0.975-0.981 
 
Racemate (EFFA, 2012g). 
Mixture of (+/-)-verbenone. 
 
09.584 
 
Isobornyl isobutyrate 
O
O
O
O
 
4146 
 
85586-67-0 
Liquid 
C14H24O2 
224.34 
Insoluble 
Freely soluble 
132 (25 hPa) 
 
MS 
95 % 
1.460-1.466 
0.958-0.964 
 
Racemate (±) = DL-
Isobornyl isobutyrate.  
CASrn in Register refers to 
(1R,2R,4R)-rel.  
Register name to be changed 
to DL-Isobornyl isobutyrate 
(EFFA, 2011m). 
 
09.848 
 
(1S-endo)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-ol 
acetate 
O
_____O
 
 
 
5655-61-8 
Solid 
C12H20O2 
196.29 
Insoluble 
Freely soluble 
225 
29 
NMR MS 
95 % 
1.456-1.462 
0.981-0.987 
 
Name to be changed to (-)-
bornyl acetate. 
09.888 
 
Isobornyl 2-methylbutyrate 
O
_____O
O
_____ O
 
4147 
 
94200-10-9 
Solid 
C15H26O2 
238.37 
Insoluble 
Freely soluble 
336 
84 
MS 
95 % 
n.a. 
n.a. 
 
Mixture of diastereoisomers. 
CASrn = 94200-10-9 
(EFFA, 2010a). 25 % of 
each (EFFA, 2012g).  
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
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TABLE 2A: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
02.119 
 
Cedrenol 
OH
34 
 
Class I 
A3: Intake below threshold 
4) 6) a) 
09.584 
 
Isobornyl isobutyrate 
O
O
O
O
0.085 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.848 
 
(1S-endo)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-
ol acetate 
O
_____O
0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.888 
 
Isobornyl 2-methylbutyrate 
O
_____O
O
_____ O
0.061 
 
Class I 
A3: Intake below threshold 
4) 6)  
07.171 
 
Isopinocamphone 
O
0.024 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.196 
 
Pin-2-en-4-one 
O  
15 
 
Class II 
A3: Intake below threshold 
4) 6) b) 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
a) Evaluated in FGE.211, genotoxicity concern could be ruled out. 
b) Evaluated in FGE.212Rev1, genotoxicity concern could be ruled out. 
. 
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 TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE ESTERS  
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
02.016 Borneol 
1385 HO
_____
OH
_____
 
No safety concern a) 
Category B b) 
 
Class I 
A3: Intake below threshold 
 
02.059 Isoborneol 
1386 
HO
_____
OH
_____
 
No safety concern a) 
Category B b) 
 
Class I 
A3: Intake below threshold 
 
08.002 Acetic acid 
81 
O
OH  
Category 1 c) 
No safety concern d) 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.006 2-Methylpropionic acid 
253 
O
OH
 
Category 1 c) 
No safety concern d) 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.046 2-Methylbutyric acid 
255 
O
OH
 
Category 1 c) 
No safety concern d) 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4) Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (JECFA, 2005c). 
b) (CoE, 1992). 
c) (SCF, 1995). 
d) (JECFA, 1999b). 
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TABLE 3: SUPPORTING SUBSTANCES SUMMARY 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
02.016 Borneol 
HO
_____
OH
_____
2157 
64 
507-70-0 
1385 
JECFA specification (JECFA, 
2005b) 
130  
No safety concern a) 
Category B b) 
 
02.038 Fenchyl alcohol 
OH
 
2480 
87 
1632-73-1 
1397 
JECFA specification (JECFA, 
2005b) 
55  
No safety concern a) 
Category B b) 
 
02.059 Isoborneol 
HO
_____
OH
_____
2158 
2020 
124-76-5 
1386 
JECFA specification (JECFA, 
2005b) 
21  
No safety concern a) 
Category B b) 
 
07.153 1,10-Dihydronootkatone O 3776 
 
20489-53-6 
1407 
JECFA specification (JECFA, 
2005b) 
0.24  
No safety concern a) 
 
 
07.159 d-Fenchone 
O
 
2479 
551 
4695-62-9 
1396 
JECFA specification (JECFA, 
2005b) 
6.3  
No safety concern a) 
 
 
07.215 (1R)-1,7,7-
Trimethylbicyclo[2.2.1]heptan
-2-one 
O
 
2230 
140 
464-49-3 
1395 
JECFA specification (JECFA, 
2005b) 
50  
No safety concern a) 
 
JECFA evaluated d-
camphor (CASrn as in 
Register). CASrn in 
Register refers to 
(1R,4R)-1,7,7-
Trimethylbicyclo(2.2.1)-
heptan-2-one (d-
camphor). 
09.017 Bornyl acetate 
O
O
O
O
2159 
207 
76-49-3 
1387 
JECFA specification (JECFA, 
2005b) 
18  
No safety concern a) 
Category B b) 
 
09.082 Bornyl formate 
O
_____O
O
_____ O
2161 
349 
7492-41-3 
1389 
JECFA specification (JECFA, 
2005b) 
1.2  
No safety concern a) 
Category B b) 
 
09.131 Isobornyl propionate 
O
_____O
O
_____ O
2163 
412 
2756-56-1 
1391 
JECFA specification (JECFA, 
2005b) 
2.6  
No safety concern a) 
Category B b) 
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09.153 Bornyl valerate 
O
_____
O
O
_____
O
2164 
471 
7549-41-9 
1392 
JECFA specification (JECFA, 
2005b) 
3.7  
No safety concern a) 
Category B b) 
 
09.176 Isobornyl formate 
O
_____O
O
_____ O
2162 
565 
1200-67-5 
1390 
JECFA specification (JECFA, 
2005b) 
0.61  
No safety concern a) 
Category B b) 
 
09.218 Isobornyl acetate 
O
_____O
O
_____ O
2160 
2066 
125-12-2 
1388 
JECFA specification (JECFA, 
2005b) 
890  
No safety concern a) 
Category B b) 
 
09.269 Fenchyl acetate 
O
O
3390 
11769 
13851-11-1 
1399 
JECFA specification (JECFA, 
2005b) 
2.9  
No safety concern a) 
 
 
09.319 Bornyl butyrate 
O
_____ O
O
_____O
3907 
 
13109-70-1 
1412 
JECFA specification (JECFA, 
2005b) 
6.1  
No safety concern a) 
 
 
09.456 Bornyl isovalerate 
O
_____O
O
_____ O
2165 
451 
76-50-6 
1393 
JECFA specification (JECFA, 
2005b) 
0.12  
No safety concern a) 
Category B b) 
 
09.457 Isobornyl isovalerate 
O
_____O
O
_____ O
2166 
452 
7779-73-9 
1394 
JECFA specification (JECFA, 
2005b) 
0.012  
No safety concern a) 
Category B b) 
 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3) No safety concern at estimated levels of intake. 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (JECFA, 2005c). 
b) (CoE, 1992). 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products8 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous9 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
8 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
9 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for the four candidate substances in the 
present flavouring group (Table II.1.2). 
Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.47Rev1 (EFFA, 
2005f; EFFA, 2006ac; EFFA, 2007a) 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
02.119 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
07.171 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
- 
- 
4 
20 
5 
25 
2 
10 
07.196 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
- 
- 
4 
20 
5 
25 
2 
10 
09.584 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
- 
- 
10 
50 
20 
100 
5 
25 
09.848 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
- 
- 
10 
50 
20 
100 
5 
25 
09.888 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
- 
- 
10 
50 
- 
- 
5 
25 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
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the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
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Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food   
 
The mTAMDI values (see Table II.2.3) are presented for each of the four flavouring substances in the 
present flavouring group, for which Industry has provided use and use levels (EFFA, 2005f; EFFA, 2006ac; 
EFFA, 2007a). The mTAMDI values are only given for the highest reported normal use levels. 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
02.119 Cedrenol 3900 Class I 1800 
09.584 Isobornyl isobutyrate 2300 Class I 1800 
09.848 (1S-endo)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol acetate 2300 Class I 1800 
09.888 Isobornyl 2-methylbutyrate 1900 Class I 1800 
07.171 Isopinocamphone 1000 Class II 540 
07.196 Pin-2-en-4-one 1000 Class II 540 
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ANNEX III: METABOLISM 
III.1. Introduction 
The present FGE consists of six substances of which three are esters of bicyclic secondary alcohols [FL-no: 
09.584, 09.848 and 09.888], one is a tricyclic alcohol [FL-no: 02.119] and two are bicyclic ketones [FL-no: 
07.171 and 07.196]. 
III.2. Absorption, Distribution, Metabolism and Excretion 
 III.2.1 Hydrolysis of Esters 
The esters within this group are expected to be hydrolysed in humans to their component alcohols and 
aliphatic carboxylic acids. Subsequently, the carboxylic acids are completely metabolised through recognised 
biochemical pathways (Nelson and Cox, 2000a). Ester hydrolysis is catalysed by classes of enzymes 
recognised as carboxylesterases (Heymann, 1980; White et al., 1990), the most important of which are the B-
esterases. In mammals, these enzymes occur in most tissues (Heymann, 1980; Anders, 1989), but 
predominate in hepatocytes (Heymann, 1980). 
III.2.2 Absorption, Distribution, Metabolism and Excretion of the alcohols and ketones 
III.2.2.1 Absorption, Distribution and Excretion 
In rabbits, more than 90 % of an oral dose of d-, l-, or d,l-bornyl acetate was excreted in the urine as the 
glucuronic acid conjugate of borneol [FL-no: 02.016] (Williams, 1959a). 
Studies in humans, dogs and rabbits, have shown that the secondary alcohols and ketones of this group are 
rapidly absorbed, distributed, metabolised and excreted mainly in the urine as glucuronide conjugates. Small 
amounts may be expired in exhaled air.  
Case reports, in which ingestion of the structurally related substance camphor [FL-no: 07.215] resulted in 
toxicity in both adults and children within minutes of exposure (Jacobziner and Raybin, 1962; Phelan, 1976; 
Kopelman et al., 1979; Gibson et al., 1989), demonstrate rapid absorption of this substance. Rabbits gavaged 
with 1.9 - 3.5 mmol/kg bw [289 - 533 mg/kg bw] d-camphor excreted 59.1 % of the dose conjugated with 
glucuronic acid in the urine within 24 hours (Robertson and Hussain, 1969). A group of 50 Sprague-Dawley 
rats was administered a single dose of 1,000 mg of 40 % camphor in cottonseed oil/kg bw (approximately 
400 mg camphor) by gavage and killed at 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 4.0, 6.0, 8.0 or 10.0 hours following 
treatment. Blood samples were taken prior to death. Peak blood concentration of camphor occurred at 96 
min, with an absorption half-life of 38 min and a plasma elimination half-life of 142 min. The authors 
considered these data to compare favourably to those in man (Dean et al., 1992).  
The toxicokinetics of d,l-camphor were studied in B6C3F1 mice and F344 rats. In mice, camphor was 
rapidly eliminated from the plasma following a single intravenous injection of 50 mg/kg bw with an 
elimination rate constant of 0.0337 and 0.0335/min
 
for males and females, respectively, and a half-live of 21 
minutes. In rats, camphor underwent biphasic elimination from plasma following a single intravenous 
injection of 6 mg/kg bw with an elimination rate constant of 0.0038 and 0.0059/min
 
for males and females, 
respectively, and half-lives of 185 (males) and 118 (females) minutes (Grizzle et al., 1996).  
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In a case report, a pregnant woman (week 40) accidentally ingested 12 g camphorated oil (% camphor not 
specified) and 36 hours later gave birth to a cyanotic baby exhibiting no respiration. The baby died within 30 
min. The presence of camphor was noted at 15 min in maternal circulation, at 20 hours in amniotic fluid, and 
at 36 hours in cord blood, infant brain, liver and kidneys (Riggs et al., 1965).  
Approximately 80 % of a 2,000 mg oral dose of d-borneol [FL-no: 02.016] given to humans (sex and number 
not specified) was excreted within 10 hours (Williams, 1959a). 
III.2.2.2 Metabolism 
The major metabolic pathway of the ketones involves reduction to the corresponding secondary alcohols, 
which are subsequently excreted primarily as the glucuronic acid conjugates (Williams, 1959a; Lington and 
Bevan, 1994; Topping et al., 1994). Metabolites excreted into the bile containing a double bond may be 
reduced to the corresponding dihydro derivatives by the gut microflora (Krasavage et al., 1982). In addition 
to reductive pathways, alicyclic ketones and, to a lesser extent, secondary alcohols containing an alkyl side-
chain undergo oxidation of the side-chain to form polar poly-oxygenated metabolites that are excreted 
mainly in the urine, either unchanged or as the glucuronide or sulphate conjugates.  
The bicyclic secondary alcohols are rapidly conjugated in humans, dogs and rabbits with glucuronic acid and 
excreted via the urine. In humans (Figure III.1), 81 and 94 % of an oral dose of 1,000 and 2,000 mg of 
borneol [FL-no: 02.016], respectively, was excreted as the glucuronic acid conjugate within 24 hours 
(Wagreich et al., 1941). At 10 hours following ingestion of 2,000 mg of borneol, 81 % of the dose was 
detected as the glucuronic acid conjugate in human urine (Quick, 1928b). At a higher dose level (i.e., 3,500 
mg borneol), 69 % of the dose was detected in human urine after 6 hours (Quick, 1928b). Similar 
conjugation has been reported in dogs (Quick, 1927; Pryde and Williams, 1934) and an increased level of β-
glucuronidase has been reported in several tissues of dogs orally administered borneol (Fishman, 1940). At 
oral doses of 100 mg/kg per day and higher, rats fed borneol over a period of 10 days showed an increase in 
the urinary levels of total glucuronic acid, o-glucuronide and ascorbic acid (Tamura et al., 1962). Fenchyl 
alcohol administered by gavage to rabbits was also excreted via urine as a glucuronide conjugate 
(Hämäläinen, 1912). 
HO
H
glu-o
H
Urine
 
 
FigureIII.1 Metabolism of borneol in humans 
In rats, pre-treated for 3 days with borneol (intraperitoneal or dietary exposure), increases of approximately 
25 % were reported in the activities of biphenyl 4-hydroxylase, glucuronyl transferase, 4-nitrobenzoate 
reductase and CYP-450 (Parke and Rahman, 1969). Rats (4/group) given 250 mg/kg bw of l-borneol by 
intraperitoneal injection daily for 3 days showed no significant increase in liver UDP-
glucuronosyltransferase (UDPGT) activity. After daily treatment for up to four weeks slight increases in the 
activity were observed. The authors concluded that over the short periods of exposure, detoxication of 
borneol does not require the induction of UDPGT; however, longer exposure periods, at high dose levels, 
necessitate UDPGT induction (Boutin et al., 1983). Conversely, in rats intubated with 3 mmol/kg bw of 
borneol [463 mg/kg bw in olive oil], the activity of hepatic S-3-hydroxy-3-methylglutaryl coenzyme A 
reductase was decreased by approximately 50 %, 17 hours after dosing (Clegg et al., 1980).  
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Cytochrome P4502B1 was induced in rat liver microsomes isolated from rats injected intraperitoneally with 
300 mg/kg bw borneol (Hiroi et al., 1995), indicating that oxidation may occur to a limited extent. Rats 
injected intraperitoneally with 1,000 mg/kg bw isobornyl acetate [FL-no: 09.218] for 3 days showed a 
minimum 2.0-fold increase in the activities of N-demethylase and NADPH cytochrome c reductase, and in 
CYP-450 content indicating that isobornyl acetate induces the microsomal mixed-function oxidase system 
(Cinti et al., 1976), which also suggests that oxidation of ring positions and ring substituents may occur. 
Ingestion of 6 to 10 gram of camphor by humans resulted in urinary excretion of 3-, 5-, 8- and 9-
hydroxycamphor, 5-ketocamphor and the carboxylic acid of either 8- or 9-hydroxycamphor, unconjugated or 
conjugated with glucuronic acid (Köppel et al., 1982). A minor amount was exhaled in expired air. 
Hydroxylation products, predominantly 5-endo- and 5-exo-hydroxycamphor and a compound resembling 3-
endo-hydroxycamphor, have also been reported when camphor was orally administered to dogs (1,000 mg 
per animal, 4 times per day via gelatine capsule for 7 days) or rabbits (300 mg per animal, single dose by 
gavage) (Leibman and Ortiz, 1973). The same camphor hydroxylation products, with a small amount of 2,5-
bornanedione, were similarly identified in vitro following incubation with rat and rabbit liver fractions 
(Leibman and Ortiz, 1973). Similar hydroxylation products (4- and 5-hydroxyfenchone and p-apofenchone-
3-carboxylic acid) were detected in the urine of dogs fed d-fenchone (Reinartz and Zanke, 1936). The 
metabolism of d-fenchone also demonstrates that hydroxylation of ring methyl substituents leads to the 
corresponding carboxylic acid derivatives. 
In rabbit liver cytosol, d-camphor was reduced via an NADPH-dependent pathway to borneol and a small 
amount of isoborneol (Robertson and Hussain, 1969; Leibman and Ortiz, 1973). In rat liver, camphor 
induced members of the P450IIB sub-family, most likely P450b and/or P450e (Austin et al., 1988). Female 
Swiss albino mice gavaged with 50, 150 or 300 mg camphor/kg bw per day in olive oil for 20 days showed a 
statistically significant increase in CYP-450 and cytochrome b5, aryl hydrocarbon hydrolase and glutathione 
S-transferase activities only at the highest dose level (Banerjee et al., 1995). 
Other minor routes of metabolism of the cyclic secondary alcohols include hydroxylation of an allylic 
position and oxidative cleavage of the strained ring in the cyclic substance. 
III.3. Conclusion 
The available data indicate that the three esters in this group [FL-no: 09.584, 09.848 and 09.888] are 
readily hydrolysed to the corresponding bicyclic secondary alcohols which are subsequently conjugated 
with glucuronic acid and excreted in the urine. Similarly conjugation with glucuronide will also occur 
with the free tri-cyclic alcohol cedrenol [FL-no: 02.119]. The major metabolic pathway of the bicyclic 
ketones [FL-no: 07.171 and 07.196], involves reduction to the corresponding secondary alcohol, which will 
be excreted primarily as the glucuronic acid conjugates. In addition to reductive pathways, alicyclic ketones 
and, to a lesser extent, secondary alcohols containing an alkyl side-chain undergo oxidation of the side-chain 
to form polar oxygenated metabolites that are excreted mainly in the urine, either unchanged or as 
glucuronide or sulphate conjugates. It is therefore concluded that the candidate substances can be 
anticipated to be metabolised to innocuous products. 
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for one candidate substance of the present Flavouring Group Evaluation, and for nine supporting substances evaluated by 
the JECFA at the 63th meeting (JECFA, 2006a). The supporting substances are listed in brackets. 
 
TABLE IV.1: ACUTE TOXICITY 
Chemical Name [FL-no]  Species  Sex  LD50 
(mg/kg bw)  
Reference  Comments 
Cedrenol [02.119] Rat NR > 5000 (Opdyke, 1975b)  
(Bornyl isovalerate [09.456]) Rat NR >5000 (Denine, 1973b)  
(Isoborneol [02.059]) Rat NR 5200 (Moreno, 1977abp)  
(Isobornyl formate [09.176])  Rat NR >5000 (Levenstein, 1975p)  
(Isobornyl acetate [09.218]) Rat M >10,000  (Fogleman and Margolin, 1970)  
(Isobornyl propionate [09.131]) Rat NR >5000  (Moreno, 1973al)  
(Fenchyl alcohol [02.038]) Rat NR ND  (Moreno, 1976ad)  
(Fenchyl acetate [09.269]) Rat NR >5000  (Moreno, 1975s)  
(1,10 Dihydronootkatone [07.153]) Rat NR >5 ml/kg (Sedlacek, 1985)  
((1R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one [07.215]) Rat NR >5000 (Moreno, 1976ac)  
Mice NR 1310 (Opdyke, 1978d)  
M=Male; F=Female; NR=Not Reported; ND=No Data. 
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Subacute / Subchronic / Chronic / Carcinogenic toxicity data are available for none of the candidate substances of the present Flavouring Group Evaluation 
but for four supporting substances evaluated by the JECFA at the 63th meeting (JECFA, 2006a). The supporting substances are listed in brackets. 
TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
Chemical Name [FL-no]  Species; Sex1 
No./Group2 
Route  Dose levels Duration NOAEL 
(mg/kg bw/day) 
Reference Comments 
(Borneol [02.016]) Dog; NR 
1/3 
Gavage 526 mg/kg bw /day 31 days 5263 (Miller et al., 1933)  
Dog; NR 
1/5 
Diet  500 mg/kg bw /day 37 days <500 (Miller et al., 1933)  
Dog; NR 
1/3 
Diet  1300 mg/kg bw /day 90 days <13004 (Miller et al., 1933)  
(Isobornyl acetate [09.218]) Rat; M, F 
3/30 
Gavage 0, 15, 90, 270 mg/kg 
bw /day 
91 days 15 (M) 
90 (F)5 
(Gaunt et al., 1971b)  
(d-Fenchone [07.159]) Dog; NR 
1/1 
Oral 1064 mg/kg bw /day 16 days <1064 (Rimini, 1901)  
((1R)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-
one [07.215]) 
Rat NR 
4/5 
Gavage 0, 250, 500, 1000, 
1200 mg/kg bw/day6 
56 days 75 (Skramlik, 1959)  
M=Male; F=Female; NR=Not reported. 
1 
Total number of test groups does not include control animals.  
2 
Total number per test group includes both male and female animals.  
3 
Study performed with either a single dose or multiple doses that produced no adverse effect.  
4 
Animals were gradually introduced to the final dose level of 1,300 mg/kg bw per day over a 2-month period.  
5 
Author specified a single NOEL of 15 mg/kg bw per day, without distinguishing between male and female rats.  
6 Study performed using sage oil at doses of 0, 250, 500, 1000 or 1200 mg/kg bw per day. With an estimated camphor content of approximately 30 %, these doses provide approximately 0, 75, 150, 300 or 360 mg/kg bw per day of camphor. 
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TABLE IV.3: DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
No developmental and reproductive toxicity data are available for the candidate substances of the present flavouring group evaluation but for one supporting 
substance evaluated by JECFA at the 63rd meeting. This supporting substance is listed in brackets. 
 
TABLE IV.3: DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
Chemical Name  Study type 
Duration 
Species/Sex  
No/group 
Route  Dose  levels (mg/kg/day) NOAEL 
(mg/kg/day) Including information 
on possible maternal toxicity 
Reference  
((1R)-1,7,7-
Trimethylbicyclo[2.2.1]heptan
-2-one [07.215]) 
Teratology 
Gestation days 6-15 
Rat; F 
 
Gavage  100, 400 and 800 No adverse effects on fetal growth, 
viability, or morphological 
development were reported. 
(NTP, 1992i)  
Teratology 
Gestation days 6-19 
Rabbit; F Gavage 0, 50, 200 and 400 No effect on fetal growth, viability or 
morphological development 
was observed. 
(NTP, 1992j)  
Teratogenicity 
Gestation days 6-17 
Rat; F Gavage 216, 464 and 1000 No evidence of teratogenicity. (Leuschner, 1997) 
Teratogenicity 
Gestation days 6-18 
Rabbit; F Gavage 147, 316 and 681  No increased incidences in variations, 
retardations or malformations were 
observed at any of the treated dose 
levels. 
(Leuschner, 1997) 
F: Female. 
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In vitro mutagenicity/genotoxicity data are available for none of the candidate substances of the present Flavouring Group Evaluation but for three supporting 
substances evaluated by the JECFA at the 63th meeting (JECFA, 2006a) as well as one structurally related supporting substance. Supporting substances are 
listed in brackets. 
TABLE IV.4: GENOTOXICITY (IN VITRO) 
Chemical Name [FL-no]  Test System Test Object  Concentration Result  Reference  Comments 
(Borneol [02.016]) Reverse mutation Salmonella typhimurium TA97, TA98, 
TA100 
1 mg/ml (1000 μg/ml) Negative1 (Azizan and Blevins, 1995)  
Reverse mutation Salmonella typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
Up to 5 mg/plate (5000 μg/plate) Negative (Simmon et al., 1977)  
DNA repair Bacillus subtilis M45
-
and H17 Up to 10 mg/disk Positive (Yoo, 1986)  
Mutation test  Escherichia coli WP2 uvrA (trp-) 0.4-3.2 mg/plate Negative (Yoo, 1986)  
(Isobornyl propionate [09.131]) Reverse mutation Salmonella typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
Up to 3.6 mg/plate (3600 μg/plate) Negative (Wild et al., 1983)  
((1R)-1,7,7-
Trimethylbicyclo[2.2.1]heptan-2-one 
[07.215]) 
Reverse mutation Salmonella typhimurium TA98, TA100, 
TA1535, TA1538 
4, 20, 100, 500 and 2500 μg/plate Negative2 (Anderson and Styles, 1978)  
Reverse mutation Salmonella typhimurium TA98, TA100, 
TA1535, TA1537, TA102 
≤ 50 μg/plate Negative3 (Marzin, 1998)  
Reverse mutation Salmonella typhimurium TA98, TA100, 
TA1535, TA1537, TA102 
≤ 150 μg/plate Negative1 (Marzin, 1998)  
Reverse mutation Salmonella typhimurium TA98, TA100, 
TA1535, TA1538 
10, 33, 100, 333 and 667 μg/plate Negative1 (NTP, 1992h)  
Sister chromatid exchange Chinese hamster ovary cells 250, 500, 750, 1000 and 1500 μg/ml Negative1,3 (NTP, 1992h)  
Sister chromatid exchange Chinese hamster ovary cells 500, 525, 550, 575 and 600 μg/ml Negative2 (NTP, 1992h)  
(d,l-Camphor) Reverse mutation Salmonella typhimurium TA97a, TA98, 
TA100, TA102 
 Negative1 (Gomes-Carneiro et al., 1998)  
1 Tested with and without metabolic activation. 
2 Tested with metabolic activation. 
3 Tested without metabolic activation. 
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In vivo mutagenicity/genotoxicity data are available for none of the candidate substances of the present Flavouring Group Evaluation but for one supporting 
substances evaluated by the JECFA at the 63th meeting (JECFA, 2006a) as well as one structurally related supporting substance. Supporting substance is listed 
in brackets. 
TABLE IV.5: GENOTOXICITY (IN VIVO) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Result  Reference  Comments 
(Isobornyl propionate [09.131]) Somatic mutation and 
recombination 
Drosophila 
melanogaster 
Oral 10 mM (2103 μg/ml) Negative (Wild et al., 1983)  
Micronucleus formation Mouse bone marrow 
cells 
IP 841, 1893, and 2944 mg/kg 
bw 
Negative1 (Wild et al., 1983)  
(d,l-Camphor) Micronucleus induuction Mouse peripheral 
blood erythrocytes 
Dermal 200, 400, 600, 800 and 1000 
mg/kg bw 
Negative2 (NTP, 1999c) Daily application, 5days/week; 13 
weeks. 
1Administered via intraperitoneal injection. 
2Administered topically. 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese Hamster Ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic Acid 
EC European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50 %; Median lethal dose 
MS  Mass Spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
NADPH Nicotinamide Adenine Dinucleotide Phosphate, reduced form 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
UDP  Uridine Diphosphate 
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UDPGT UDP-glucuronosyltransferase 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation  
